Mark L. Levitt
Director Técnico/Científico/I+D en REDHILL BIOPHARMA LTD. .
Perfil
Mark L.
Levitt is currently the Director at EnGeneIC Pty Ltd.
and the Chief Scientific Officer at RedHill Biopharma Ltd.
He previously worked as the Director at UPMC Cancer Institute and as the Head-Lung Cancer Unit at Sheba Medical Center.
Cargos activos de Mark L. Levitt
Empresas | Cargo | Inicio |
---|---|---|
REDHILL BIOPHARMA LTD. | Director Técnico/Científico/I+D | 01/01/2022 |
EnGeneIC Pty Ltd.
EnGeneIC Pty Ltd. BiotechnologyHealth Technology EnGeneIC Pty Ltd. develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer. It offers targeted drug delivery, gene silencing, canine cancers and principal characteristics technology solutions. The company was founded by Jennifer A. MacDiarmid and Himanshu Brahmbhatt in 2001 and is headquartered in Sydney, Australia. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Mark L. Levitt.
Empresas | Cargo | Fin |
---|---|---|
UPMC Cancer Institute
UPMC Cancer Institute Medical/Nursing ServicesHealth Services UPMC Cancer Institute provides health care and insurance services. The company was founded in 1985 and is headquartered in Pittsburgh, PA. | Director/Miembro de la Junta | - |
Sheba Medical Center
Sheba Medical Center Hospital/Nursing ManagementHealth Services Sheba Medical Center is a hospital engaging in medical science and biotechnical innovation. Its services include emergency room services, cancer treatment, psychiatry, and hematological examination. The company was founded on June 21, 1948 and is headquartered in Ramat Gan, Israel. | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
REDHILL BIOPHARMA LTD. | Health Technology |
Empresas privadas | 3 |
---|---|
EnGeneIC Pty Ltd.
EnGeneIC Pty Ltd. BiotechnologyHealth Technology EnGeneIC Pty Ltd. develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer. It offers targeted drug delivery, gene silencing, canine cancers and principal characteristics technology solutions. The company was founded by Jennifer A. MacDiarmid and Himanshu Brahmbhatt in 2001 and is headquartered in Sydney, Australia. | Health Technology |
Sheba Medical Center
Sheba Medical Center Hospital/Nursing ManagementHealth Services Sheba Medical Center is a hospital engaging in medical science and biotechnical innovation. Its services include emergency room services, cancer treatment, psychiatry, and hematological examination. The company was founded on June 21, 1948 and is headquartered in Ramat Gan, Israel. | Health Services |
UPMC Cancer Institute
UPMC Cancer Institute Medical/Nursing ServicesHealth Services UPMC Cancer Institute provides health care and insurance services. The company was founded in 1985 and is headquartered in Pittsburgh, PA. | Health Services |
- Bolsa de valores
- Insiders
- Mark L. Levitt